tirzepatide vs semaglutide inflammation caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide what's the difference of tirzepatide

We only consider a partial dose no lower than half the strength stated on the pen

The mechanism of actionappetite reduction plus metabolic enhancementis the same

What if I cannot tolerate the starting dose of tirzepatide

The GDS-15 was completed by 34 patients (17 per group), with median scores initially at 2.0 in the loading dose group and 3.5 in the no loading dose group, which adjusted to 2.5 and 2.0 respectively after 90 days

Based on your responses, they determine whether a GLP-1 treatment such as semaglutide or tirzepatide is appropriate for you

A plateau at 12 weeks typically indicates metabolic adaptation rather than peptide resistance